Last reviewed · How we verify

NCT05870332: NAIAD

Nationwide Study of Artificial Intelligence in Adenoma Detection for Colonoscopy

Status unknown Last updated 6 March 2024
What this trial tests

trial testing GI Genius (GIG) in Colonic Polyp in 4,000 participants. Status unknown.

Timeline
16 October 2023
Primary endpoint
1 January 2025
31 May 2025

Quick facts

Lead sponsorKing's College Hospital NHS Trust
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment4,000
Start date16 October 2023
Primary completion1 January 2025
Estimated completion31 May 2025
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

King's College Hospital NHS Trust

Who can join

Adults 18 to 85, any sex, with Colonic Polyp or Colonic Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this trial is to determine whether use of a Computer Assisted Detection (CADe) programme leads to an increase in ADR for either units or individual colonoscopists, independent of setting or expertise

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Colonic Polyp

Currently open trials in the same condition.

Other King's College Hospital NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05870332.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing